NASDAQ:MTBCMTBC Stock Price, Forecast & News

$10.52

+0.07 (+0.67 %)

(As of 07/10/2020 04:00 PM ET)

Add

Compare

Today's Range

$10.40

Now: $10.52▼

$11.15

50-Day Range

$6.27

MA: $7.79▼

$11.11

52-Week Range

$3.25

Now: $10.52▼

$11.84

Volume215,300 shs

Average Volume171,702 shs

Market Capitalization$130.45 million

P/E RatioN/A

Dividend YieldN/A

Beta1.11

MTBC, Inc., a healthcare information technology (IT) company, provides an integrated suite of Web-based solutions and related business services to healthcare providers primarily in the United States. The company operates through two segments, Healthcare IT and Practice Management. It primarily offers PracticePro, a software-as-a-service platform, which includes practice management software and related tools that facilitate the day-to-day business operation and workflows; electronic health record (EHR), which enables customers to reduce paperwork; revenue cycle management services, such as end-to-end medical billing, analytics, and related services; and mobile health solutions, including smartphone applications that assist patients and healthcare providers in the provision of healthcare services. The company also provides a web-based EHR solution; healthcare claims clearinghouse services; transcription, coding, indexing, and other ancillary services; electronic data interchange services; talkEHR, a voice enabled EHR solution; business intelligence, customized applications, interfaces, and various other technology solutions; comprehensive practice management services; telemedicine services; and patient experience management solutions. It serves physicians, nurses, nurse practitioners, physician assistants, and other clinical staff that render bills for their services. The company was formerly known as Medical Transcription Billing, Corp. and changed its name to MTBC, Inc. in February 2019. MTBC, Inc. was founded in 1999 and is headquartered in Somerset, New Jersey.

Beat the Market (BTM) Rank^™

2.5 Analyst's Opinion

Consensus Rating
MTBC has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 7 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $9.80, MTBC has a potential downside of 6.8% from its current price of $10.52.
Amount of Analyst Coverage
MTBC has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

2.6 Community Rank

Outperform Votes
MTBC has received 243 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
MTBC has received 226 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
MTBC has received 51.81% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about MTBC and other stocks. Vote “Outperform” if you believe MTBC will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MTBC will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
MTBC does not currently pay a dividend.
Dividend Growth
MTBC does not have a long track record of dividend growth.

1.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, MTBC insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $543,377.00 in company stock.
Percentage Held by Insiders
46.00% of the stock of MTBC is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
Only 17.02% of the stock of MTBC is held by institutions.

0.6 Earnings and Valuation

Earnings Growth
Earnings for MTBC are expected to grow in the coming year, from ($1.30) to ($0.64) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of MTBC is -12.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of MTBC is -12.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
MTBC has a P/B Ratio of 3.00. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

1.35 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Prepackaged software

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:MTBC

Previous Symbol

CUSIPN/A

CIK1582982

Webwww.mtbc.com

Phone732-873-5133

Debt

Debt-to-Equity Ratio0.24

Current Ratio1.29

Quick Ratio1.26

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$64.44 million

Price / Sales2.02

Cash Flow$0.33 per share

Price / Cash Flow32.02

Book Value$3.51 per share

Price / Book3.00

Profitability

EPS (Most Recent Fiscal Year)($0.60)

Net Income$-870,000.00

Net Margins-6.41%

Return on Equity-10.63%

Return on Assets-7.42%

Miscellaneous

Employees2,700

Outstanding Shares12,400,000

Market Cap$130.45 million

Next Earnings Date8/5/2020 (Estimated)

OptionableNot Optionable

Receive MTBC News and Ratings via Email

Sign-up to receive the latest news and ratings for MTBC and its competitors with MarketBeat's FREE daily newsletter.

MTBC (NASDAQ:MTBC) Frequently Asked Questions

How has MTBC's stock been impacted by COVID-19 (Coronavirus)?

MTBC's stock was trading at $5.31 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MTBC stock has increased by 98.1% and is now trading at $10.52. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of MTBC?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MTBC in the last year. There are currently 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for MTBC.

When is MTBC's next earnings date?

MTBC is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for MTBC.

How were MTBC's earnings last quarter?

MTBC, Inc (NASDAQ:MTBC) posted its quarterly earnings data on Thursday, May, 14th. The technology company reported ($0.42) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.64) by $0.22. The technology company had revenue of $21.87 million for the quarter, compared to analysts' expectations of $21.37 million. MTBC had a negative return on equity of 10.63% and a negative net margin of 6.41%. View MTBC's earnings history.

What guidance has MTBC issued on next quarter's earnings?

MTBC issued an update on its FY 2020 IntraDay earnings guidance on Tuesday, July, 7th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $105-107 million, compared to the consensus revenue estimate of $102.57 million.

What price target have analysts set for MTBC?

7 Wall Street analysts have issued 12-month target prices for MTBC's stock. Their forecasts range from $7.50 to $15.00. On average, they expect MTBC's stock price to reach $9.80 in the next twelve months. This suggests that the stock has a possible downside of 6.8%. View analysts' price targets for MTBC.

What are Wall Street analysts saying about MTBC stock?

Here are some recent quotes from research analysts about MTBC stock:

1. March quarter report yesterday validates CareCloud integrationabove and beyond our expectations, but.... MTBC reported 1Q20sales of $21.9M, up 45% from 1Q19's $15.1M on an apples-to-orangesbasis in light of the January 8 closing of CareCloud and the expectedincremental $30-31M in additive sales contribution this year. Further andinterestingly, MTBC has launched its formal "MTBC Force" initiative, amercenary approach to providing services to companies that have greatcustomer interface, but are perhaps weaker on the cost efficiency sideof service and support infrastructure. With three such deals under theirbelt, MTBC management appeared calm, cool, and not exceedinglyambitious in again delivering its $100-102M in sales guidance for 2020yesterday" (5/15/2020)
2. We reiterate our Buy rating on MTBC following Q1 results that beat expectations acrossrevenue, EBITDA and EPS. Q1 was the first quarter in which the CareCloud acquisitioncontributed, and registered a small top-line beat relative to our expectations. Owingto COVID and the precipitous decline in physician visits entering Q2, MTBC expectsQ2 to be down sequentially, with negative EBITDA and EPS. This is not a surprise asfully 60% of MTBC revenue is dependent on physician volumes and charges. Still, MTBCreiterated its full-year view of $100M to $102M in revenue and $12-$13M EBITDA asit has multiple paths to get there, namely its growing Force partner program, and verylikely an acquisition of a tuck-in nature. Depending on the size of the deal, we thinkMTBC could exceed guidance, but for now we have not built any acquired growth in ourmodel and remain slightly below management’s outlook." (5/15/2020)

Has MTBC been receiving favorable news coverage?

Headlines about MTBC stock have trended negative recently, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. MTBC earned a coverage optimism score of -2.4 on InfoTrie's scale. They also assigned news headlines about the technology company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the stock's share price in the immediate future. View the latest news about MTBC.

Are investors shorting MTBC?

MTBC saw a increase in short interest in the month of June. As of June 15th, there was short interest totaling 180,400 shares, an increase of 12.7% from the May 31st total of 160,100 shares. Based on an average trading volume of 159,800 shares, the short-interest ratio is currently 1.1 days. Approximately 2.7% of the shares of the company are sold short. View MTBC's Current Options Chain.

Who are some of MTBC's key competitors?

Some companies that are related to MTBC include Magic Software Enterprises (MGIC), American Software (AMSWA), ChannelAdvisor (ECOM), Rosetta Stone (RST), Rand Worldwide (RWWI), Benefitfocus (BNFT), Grid Dynamics (GDYN), eGain (EGAN), Cheetah Mobile (CMCM), Avid Technology (AVID), Iclick Interactive Asia Group (ICLK), Shotspotter (SSTI), Xunlei (XNET), Kura Sushi USA (WIMI) and MiX Telematics (MIXT). View all competitors.

What other stocks do shareholders of MTBC own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MTBC investors own include Inseego (INSG), NVIDIA (NVDA), Square (SQ), Marvell Technology Group (MRVL), iCAD (ICAD), InVitae (NVTA), Alibaba Group (BABA), Crispr Therapeutics (CRSP), EXACT Sciences (EXAS) and Aptiv (APTV).

What is MTBC's stock symbol?

MTBC trades on the NASDAQ under the ticker symbol "MTBC."

How do I buy shares of MTBC?

Shares of MTBC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is MTBC's stock price today?

One share of MTBC stock can currently be purchased for approximately $10.52.

How big of a company is MTBC?

MTBC has a market capitalization of $130.45 million and generates $64.44 million in revenue each year. The technology company earns $-870,000.00 in net income (profit) each year or ($0.60) on an earnings per share basis. MTBC employs 2,700 workers across the globe.

What is MTBC's official website?

The official website for MTBC is www.mtbc.com.

How can I contact MTBC?

MTBC's mailing address is 7 CLYDE ROAD, SOMERSET NJ, 08873. The technology company can be reached via phone at 732-873-5133.

This page was last updated on 7/10/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings